Health Canada Approves BAVENCIO® for the Maintenance Treatment of Patients with Advanced Bladder Cancer

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}.prngen2{BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em}.prntac{TEXT-ALIGN: CENTER}.prnsbt0{BORDER-TOP:0pt}.prnbcc{BORDER-COLLAPSE: COLLAPSE}.prnsbl0{BORDER-LEFT:0pt}.prnsbb0{BORDER-BOTTOM:0pt}.prnsbr0{BORDER-RIGHT:0pt}   Canada NewsWire BAVENCIO is the first and

Read more